Accessibility: s|M|L|Text Only
send to a colleagueSend to a Friend

Microsulis Medical Limited

Parent CompanyN/A
Product RangeMicrowave Tissue Ablation (‘MTA’) and Microwave Tubal Occlusion (‘MTO’),
OperationMicrosulis’ strategy is to derive revenue growth both from increasing the market share of its existing products as well as through the introduction of new products. The Company is currently focused on the development of a number of new products including specific research on:
Microwave Fibroid Debulking, Microwave Endometriosis Treatment, Microwave Ablation of Renal Cancer, Microwave Ablation of Prostate Cancer and Benign Prostate Hyperplasia (BPH), Microwave Ablation of Brain Tumours, Microwave Assisted Drug Delivery, Microwave Psoriasis Treatment, Microwave Varicose Veins Treatment. The Company is also researching further product developments related to application of small diameter flexible applicators and treatment of general skin conditions in addition to possible research into cutaneous leishmaniasis.
ContactN/A
AddressHerriot Watt University Research Park
Centre for Research & Product Development
EH14 4AP
Phone+44 (0) 131 449 8750
Fax+44 (0) 131 449 8787
Mailinfo@microsulis.com
Webhttp://www.microsulis.co.uk/
NationalityN/A
EmployeesN/A
TurnoverN/A
Latest News
Upcoming Events
»New life forms in the BioQuarter
Last week's groundbreaking deal to fund the development of the first BioQuarter outside the US at Little France in Edinburgh was a reminder that, among other things, economic development is alive and kicking
»New life forms in the BioQuarter
Last week's groundbreaking deal to fund the development of the first BioQuarter outside the US at Little France in Edinburgh was a reminder that, among other things, economic development is alive and kicking
 
 
From The Directory

Valid HTML 4.01   W3C Validated CSS   conforms to W3C WCAG 1.0 Triple-A   Search Engine Friendly